A survey of UK General Practitioners about depression, antidepressants and withdrawal: Implementing the 2019 Public Health England Report
Article
Read, J., Renton, J., Harrop, C., Geekie, J. and Dowrick, C. 2020. A survey of UK General Practitioners about depression, antidepressants and withdrawal: Implementing the 2019 Public Health England Report. Therapeutic Advances in Psychopharmacology. 10. https://doi.org/10.1177/2045125320950124
Authors | Read, J., Renton, J., Harrop, C., Geekie, J. and Dowrick, C. |
---|---|
Abstract | Background: In 2019 a literature review indicated that more than half of people who try to come off antidepressants experience withdrawal effects. Both NICE guidelines and the Royal College of Psychiatrists updated their positions in line with that review, and Public Health England published a 152-page report called Dependence and withdrawal associated with some prescribed medicines: an evidence review. The report made several recommendations relevant to GP practice. Method: In order to facilitate implementation of these recommendations an online survey was designed to explore UK GPs’ experiences, opinions, knowledge and needs in relation to depression, antidepressants, and withdrawal. 66 GPs had completed the survey when COVID-19 occurred. Results: In keeping with previous findings, this small sample of GPs had a predominantly psycho-social perspective on the causes of, and treatments for, depression. They broadly considered antidepressants effective for moderate/severe depression and ineffective for minimal/mild depression, for which they preferred psychological therapies and social prescribing. There was a marked lack of consistency in GPs’ knowledge about the incidence and duration of withdrawal effects. Only a minority (29%) felt their knowledge about withdrawal was ‘adequate’ and fewer (17%) believed this about their ‘Ability to distinguish between withdrawal effects and return of the original problem (eg depression)’. Two thirds (68%) would like more training on these matters. Conclusion: It is hoped that even this small sample will be helpful when designing, and seeking funding for, GP training programmes, and when implementing the PHE recommendations for support services, based in the primary care system, for the millions of people contemplating or initiating withdrawal from antidepressants every year in the UK. |
Journal | Therapeutic Advances in Psychopharmacology |
Journal citation | 10 |
ISSN | 2045-1253 |
Year | 2020 |
Publisher | SAGE Publications for British Association for Psychopharmacology |
Accepted author manuscript | License File Access Level Repository staff only |
Publisher's version | License File Access Level Anyone |
Digital Object Identifier (DOI) | https://doi.org/10.1177/2045125320950124 |
Publication dates | |
Online | 27 Aug 2020 |
Publication process dates | |
Accepted | 22 Jul 2020 |
Deposited | 30 Jul 2020 |
Copyright holder | © 2020 The Authors |
https://repository.uel.ac.uk/item/8843x
Download files
276
total views144
total downloads0
views this month0
downloads this month